Frequent BCOR aberrations in extranodal NK/T‐Cell lymphoma, nasal type. Issue 5 (10th February 2016)

• Record Type: Journal Article
• Authors: Dobashi, Akito; Tsuyama, Naoko; Asaka, Reimi; Togashi, Yuki; Ueda, Kyoko; Sakata, Seiji; Baba, Satoko; Sakamoto, Kana; Hatake, Kiyohiko; Takeuchi, Kengo
• Is Part Of: Genes, chromosomes & cancer. Volume 55:Issue 5(2016:May)
• Page Start: 460
• Page End: 471
• Publication Date: 2016-02-10
• Subjects: Cancer -- Genetic aspects -- Periodicals; 616.994042
• DOI: 10.1002/gcc.22348
• Languages: English
• ISSNs: 1045-2257

Abstract

Abstract : Extranodal natural killer/T cell lymphoma (ENKTL) is a rare subtype of lymphoma. Recurrent mutations in the JAK‐STAT pathway, recently reported in ENKTL cases, are interesting in terms of both pathogenesis and inhibitor therapy. However, the frequencies of these mutations are low and variable among reports, and other pathognomonic mutations in ENKTL remain to be elucidated. In the present study, targeted capture sequencing of 602 cancer‐related genes from 25 frozen ENKTL samples was performed, 11 of which were matched to normal samples. Several recurrent somatic mutations involving BCOR (32%), TP53 (16%), DDX3X (12%), FAT4 (8%), NRAS (8%), MLL3 (12%), and MIR17HG (8%) were identified. The pattern of BCOR aberrations (1 nonsense and 5 frame‐shift mutations, a mutation leading to a splicing error, and gene loss) suggested that loss of function of BCOR was the functionally important outcome of such changes. The literature was reviewed and the public data on BCOR aberrations was reanalyzed and it was found that the aberrations were frequently found in myeloid neoplasms, but, interestingly, were highly specific to ENKTL among lymphoid malignancies. Given the high frequency and pattern of aberration, BCOR is likely to play an important role in ENKTL pathogenesis as a tumor suppressor gene. © 2016 Wiley Periodicals, Inc.